Skip to content

INSYTE with SurePlanTM LiverY90

INSYTE with SurePlanTM Liver Y90


Collaboration between Sirtex Medical and MIM Software Inc. advances innovation and increases precision of liver-directed oncology therapies for patients.


Key Features


Inyte Logo



MIM Software Inc. is the legal manufacturer of the SurePlan LiverY90 Software.
SurePlan is a trademark of MIM Software Inc.

Indications for Use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intrahepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.